Endothelial dysfunction after androgen deprivation therapy and the possible underlying mechanisms-Reference-Cited by-同舟云学术

Endothelial dysfunction after androgen deprivation therapy and the possible underlying mechanisms

Published:2021-09-27 Issue:1 Volume:82 Page:13-25
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Teoh Jeremy Yuen‐Chun¹^ORCID,Tian Xiao‐Yu²^ORCID,Wong Christine Yim‐Ping¹^ORCID,Lau Chi‐Wai²,Cheng Chak‐Kwong²^ORCID,Tang Victor Wai‐Lun³,Chan Ronald Cheong‐Kin⁴^ORCID,Huang Yu²^ORCID,Ng Chi‐Fai¹^ORCID

Affiliation:

1. S.H. Ho Urology Centre, Department of Surgery The Chinese University of Hong Kong Hong Kong China

2. Institute of Vascular Medicine, School of Biomedical Sciences, Faculty of Medicine The Chinese University of Hong Kong Hong Kong China

3. Department of Clinical Pathology Pamela Youde Nethersole Eastern Hospital Hong Kong China

4. Department of Anatomical and Cellular Pathology The Chinese University of Hong Kong Hong Kong China

Funder

Ipsen Fund

Ferring

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24244

Reference39 articles.

1. Non‐steroidal antiandrogen monotherapy compared with luteinising hormone‐releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer;Kunath F;Cochrane Database Syst Rev,2014

2. Cardiovascular risk after androgen deprivation therapy for prostate cancer: an Asian perspective

3. Are all gonadotrophin-releasing hormone agonists equivalent for the treatment of prostate cancer? A systematic review

4. Cardiovascular risk after androgen deprivation therapy for prostate cancer: an Asian perspective

5. Risk of acute myocardial infarction after androgen-deprivation therapy for prostate cancer in a Chinese population

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology;Frontiers in Oncology;2024-01-31

2. Secondary Cancer after Androgen Deprivation Therapy in Prostate Cancer: A Nationwide Study;The World Journal of Men's Health;2024

3. Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis;Frontiers in Aging;2023-06-13

4. Uncovering the Secrets of Prostate Cancer’s Radiotherapy Resistance: Advances in Mechanism Research;Biomedicines;2023-06-03

5. Adverse metabolic consequences of androgen deprivation therapy (ADT) on Asian patients with prostate cancer: Primary results from the real‐life experience of ADT in Asia (READT) study;The Prostate;2023-03-20